Trials / Conditions / Controlled Ovarian Stimulation

Controlled Ovarian Stimulation

12 registered clinical trials studyying Controlled Ovarian Stimulation.

Status	Trial	Sponsor	Phase
Completed	Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracyto NCT05499052	Ferring Pharmaceuticals	—
Completed	Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic NCT04503707	Ferring Pharmaceuticals	—
Unknown	N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS NCT04122729	Angelini Farmacéutica	—
Terminated	Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using R NCT03697031	Ferring Pharmaceuticals	—
Completed	A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELL NCT03564509	Ferring Pharmaceuticals	Phase 2
Completed	Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracyt NCT03393780	Ferring Pharmaceuticals	—
Completed	Progesterone Variation on the Final Day of Oocyte Maturation. NCT03366025	Fundacion Dexeus	—
Completed	To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran® NCT03051087	LG Life Sciences	Phase 4
Completed	Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin NCT01339299	Regionshospitalet Viborg, Skive	Phase 4
Completed	A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Con NCT00725491	Organon and Co	Phase 3
Completed	Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED) NCT00988260	Organon and Co	Phase 2
Withdrawn	Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols NCT01510054	Johns Hopkins University	—